 |
Adam Bonislawski is the editor of GenomeWeb's ProteoMonitor. He covers proteomics and life science mass spectrometry. E-mail Adam Bonislawski and follow his GenomeWeb Twitter account at @ProteoMonitor. |
Myriad RBM Collaborating with Max Planck on Test for Early Detection of Colon Cancer
May 11, 2012
Myriad RBM Collaborating with Max Planck on Test for Early Detection of Colon Cancer
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- CPTAC, Seoul National University to Test Proteomic Workflows Including MRM-MS in Clinical Setting
February 8, 2013 / ProteoMonitor - GMU Phosphoproteomic Studies Offer Potential Clinical Insights on Breast, Colorectal Cancers
October 12, 2012 / ProteoMonitor - Citing Validation Costs, IP Concerns, Reference Labs Offer Gloomy Take on Protein Biomarker Tests
May 25, 2012 / ProteoMonitor - Myriad RBM Teams with Spinal Muscular Atrophy Foundation on Protein Marker Panel
April 6, 2012 / ProteoMonitor - Calling for Stronger Clinical Focus, Researchers Question Priorities of NCI's CPTAC Initiative
February 17, 2012 / ProteoMonitor